首页BIOG-B • STO
add
拜奥
昨日收盘价
kr 105.80
当日价格范围
kr 105.90 - kr 107.00
年度波幅
kr 94.75 - kr 136.60
市值
103.11亿 SEK
平均交易量
40.65万
市盈率
-
股息率
-
主要交易所
STO
市场资讯
财务信息
损益表
收入
净收入
| (SEK) | 2024年9月info | 年同比变化 |
|---|---|---|
收入 | 3.04亿 | -4.32% |
经营支出 | 1.25亿 | 7.14% |
净收入 | 3660.20万 | -63.94% |
净利润率 | 12.04 | -62.32% |
每股收益 | — | — |
息税折旧摊销前利润 | 1.04亿 | -16.66% |
有效税率 | 22.09% | — |
资产负债表
总资产
负债总额
| (SEK) | 2024年9月info | 年同比变化 |
|---|---|---|
现金及短期投资 | 11.15亿 | -23.26% |
总资产 | 19.05亿 | -17.33% |
负债总额 | 2.85亿 | -10.62% |
权益总额 | 16.20亿 | — |
发行在外的股份 | 1.01亿 | — |
市净率 | 6.61 | — |
资产回报率 | 12.79% | — |
资本回报率 | 15.24% | — |
现金流
现金净变动
| (SEK) | 2024年9月info | 年同比变化 |
|---|---|---|
净收入 | 3660.20万 | -63.94% |
来自运营的现金 | 1.00亿 | 1.06% |
投资现金 | -280.60万 | 68.53% |
融资现金 | 1422.60万 | 939.29% |
现金净变动 | 1.07亿 | 28.81% |
自由现金流 | 7440.72万 | 104.18% |
简介
BioGaia is a Swedish biotechnology company that develops, markets and sells a range of probiotic products. It has patented the use of several Lactobacillus reuteri strains and offers gut and immune health products containing L. reuteri Protectis. Their oral health products contain L. reuteri Prodentis, a blend of the L. reuteri strains DSM 17938 and ATCC PTA 5289. Products containing L. reuteri have been proven to be both effective and safe in several applications: infant colic, diarrhea prevention and mitigation in children, eradication of H. pylori infection and reduction of side effects from standard H. pylori treatment, amelioration of gingivitis, and general illness prevention in children and adults. BioGaia was ranked 9th in the Top 30 Global Probiotic Food Ingredient Companies list by FoodTalks in 2021. The BioGaia -B share is listed on the NASDAQ OMX Nordic Exchange. Wikipedia
CEO
成立时间
1990
员工数量
222
